首页 | 本学科首页   官方微博 | 高级检索  
     


Design and synthesis of oxaprozin-1,3,4-oxadiazole hybrids as potential anticancer and antibacterial agents
Authors:Parsharamulu Rayam  Naveen Polkam  Naveen Kuntala  Venkanna Banothu  Hasitha Shilpa Anantaraju  Yogeeswari Perumal  Sridhar Balasubramanian  Jaya Shree Anireddy
Affiliation:1. Centre for Chemical Sciences and Technology, IST, Jawaharlal Nehru Technological University Hyderabad, Kukatpally, Hyderabad, Telangana State, India;2. Department of Biotechnology, IST, Jawaharlal Nehru Technological University Hyderabad, Kukatpally, Hyderabad, Telangana State, India;3. Department of Pharmacy, Birla Institute of Technology and Science, Pilani, Hyderabad, Telangana State, India;4. X-ray Crystallography Division, CSIR-Indian Institute of Chemical Technology, Hyderabad, Telangana State, India
Abstract:In the present study, we report design, synthesis and screening of new novel 5-substituted-2-mercapto-1,3,4-oxadiazole analogues appended to oxaprozin for their in vitro anticancer and antibacterial activity. The synthesised compounds were characterized using various spectroscopic techniques. Furthermore, the structure of 5b (2-(2-[4,5-diphenyloxazol-2-yl]ethyl)-5-(ethylthio)-1,3,4-oxadiazole) was unequivocally confirmed by X-ray analysis. Among the series 5c (2-(2-[4,5-diphenyloxazol-2-yl]ethyl)-5-(propylthio)-1,3,4-oxadiazole) showed most promising anticancer activity against A549 cancer cell line and all the reported analogues manifested satisfactory safety profiles against human normal cell line HEK293T. The products exhibited good antibacterial activity and among the tested 5j (2-(2-[4,5-diphenyloxazol-2-yl]ethyl)-5-([4-fluorobenzyl]thio)-1,3,4-oxadiazole) exhibited most potent.
Keywords:
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号